Eye health professionals welcome the first ever Public Health Indicator for eye health
Eye health professionals from across the sector will welcome the first ever Public Health Indicator for eye health when it comes into force on April 1st, 2013. As part of the new Public Health Outcomes Framework, the Indicator will track changes in the numbers of people who are certified as blind or partially sighted and
Cataract shared decision making tool
The Royal College of Ophthalmologists has collaborated with Right Care on a Shared Decision Making Aid to help inform patients about cataracts and treatment options.The new online tool is accessible on the Shared Decision Making website. The Patient Decision Aids have associated Apps, with versions for Android and Apple devices. Patients can download them from
Review of ranibizumab in patients with diabetic macular oedema
Statement on the rapid review of the technology appraisal of the use of intravitreal ranibizumab in patients with diabetic macular oedema (DMO) Review of Ranibizumab for DMO
NICE rapid review of previous technology appraisal – intravitreal ranibizumab with DMO
College Statement The National Institute of Clinical Excellence (NICE) has completed a rapid review of the previous technology appraisal of the use of intravitreal ranibizumab in patients with diabetic macular oedema. The new guidance document on ranibizumab for diabetic macular oedema, (TA274), published on 27 February 2013, recommends that patients with DMO can be commenced
Updated guidance on Emergency Eye Care
An eye condition is an emergency if its occurrence is unpredictable and it requires treatment or admission at short notice to avoid damage to the eye or eyesight. The College will not attempt to identify every type of case that falls into the emergency category: it is the responsibility of the consultant under whose care